FAB · First Trust Multi Cap Value AlphaDEX Fund
$108.17
+0.24 (+0.22%)
At close · Aug 14
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
First Trust Health Care AlphaDEX Fund
Reported 2026-01-31Net Assets
$927,202,439
Total Assets
$927,954,563
Holdings
78
Filed
2026-03-25
| Holding | CUSIP | Balance | Units | Value | % Net Assets | Category | Country |
|---|---|---|---|---|---|---|---|
| Organon & Co | 68622V106 | 2,870,897 | NS | $24,517,460 | 2.64% | EC | US |
| Pfizer Inc | 717081103 | 826,680 | NS | $21,857,419 | 2.36% | EC | US |
| HCA Healthcare Inc | 40412C101 | 44,091 | NS | $21,528,313 | 2.32% | EC | US |
| Cardinal Health Inc | 14149Y108 | 100,168 | NS | $21,524,100 | 2.32% | EC | US |
| Ionis Pharmaceuticals Inc | 462222100 | 260,200 | NS | $21,510,734 | 2.32% | EC | US |
| Medpace Holdings Inc | 58506Q109 | 36,650 | NS | $21,347,892 | 2.30% | EC | US |
| Molina Healthcare Inc | 60855R100 | 118,615 | NS | $21,302,068 | 2.30% | EC | US |
| Biogen Inc | 09062X103 | 116,963 | NS | $21,040,474 | 2.27% | EC | US |
| Incyte Corp | 45337C102 | 208,408 | NS | $20,855,389 | 2.25% | EC | US |
| Natera Inc | 632307104 | 89,852 | NS | $20,768,391 | 2.24% | EC | US |
| Solventum Corp | 83444M101 | 259,771 | NS | $19,994,574 | 2.16% | EC | US |
| Eli Lilly & Co | 532457108 | 19,154 | NS | $19,865,571 | 2.14% | EC | US |
| Acadia Healthcare Co Inc | 00404A109 | 1,450,624 | NS | $19,496,387 | 2.10% | EC | US |
| Universal Health Services Inc | 913903100 | 94,414 | NS | $19,001,762 | 2.05% | EC | US |
| Penumbra Inc | 70975L107 | 52,965 | NS | $18,970,474 | 2.05% | EC | US |
| Insmed Inc | 457669307 | 118,274 | NS | $18,553,642 | 2.00% | EC | US |
| Merck & Co Inc | 58933Y105 | 156,445 | NS | $17,251,190 | 1.86% | EC | US |
| Amgen Inc | 031162100 | 50,310 | NS | $17,199,983 | 1.86% | EC | US |
| Sotera Health Co | 83601L102 | 933,528 | NS | $16,915,527 | 1.82% | EC | US |
| Perrigo Co PLC | 000000000 | 1,183,006 | NS | $16,810,515 | 1.81% | EC | IE |
| Cigna Group/The | 125523100 | 59,833 | NS | $16,400,824 | 1.77% | EC | US |
| IDEXX Laboratories Inc | 45168D104 | 24,342 | NS | $16,320,337 | 1.76% | EC | US |
| Elevance Health Inc | 036752103 | 46,976 | NS | $16,241,482 | 1.75% | EC | US |
| Zimmer Biomet Holdings Inc | 98956P102 | 183,136 | NS | $15,945,652 | 1.72% | EC | US |
| United Therapeutics Corp | 91307C102 | 33,796 | NS | $15,866,884 | 1.71% | EC | US |
| Regeneron Pharmaceuticals Inc | 75886F107 | 21,334 | NS | $15,818,094 | 1.71% | EC | US |
| Sarepta Therapeutics Inc | 803607100 | 765,216 | NS | $15,564,493 | 1.68% | EC | US |
| Repligen Corp | 759916109 | 100,498 | NS | $15,011,386 | 1.62% | EC | US |
| Apellis Pharmaceuticals Inc | 03753U106 | 655,551 | NS | $14,802,342 | 1.60% | EC | US |
| QIAGEN NV | 000000000 | 274,182 | NS | $14,715,348 | 1.59% | EC | NL |
| Abbott Laboratories | 002824100 | 131,436 | NS | $14,365,955 | 1.55% | EC | US |
| Gilead Sciences Inc | 375558103 | 100,624 | NS | $14,283,577 | 1.54% | EC | US |
| Labcorp Holdings Inc | 504922105 | 49,229 | NS | $13,366,658 | 1.44% | EC | US |
| Quest Diagnostics Inc | 74834L100 | 71,174 | NS | $13,311,673 | 1.44% | EC | US |
| Halozyme Therapeutics Inc | 40637H109 | 183,515 | NS | $13,159,861 | 1.42% | EC | US |
| Globus Medical Inc | 379577208 | 141,457 | NS | $12,827,321 | 1.38% | EC | US |
| Bristol-Myers Squibb Co | 110122108 | 228,971 | NS | $12,604,854 | 1.36% | EC | US |
| Chemed Corp | 16359R103 | 28,867 | NS | $12,330,250 | 1.33% | EC | US |
| Neurocrine Biosciences Inc | 64125C109 | 87,079 | NS | $11,847,969 | 1.28% | EC | US |
| Tenet Healthcare Corp | 88033G407 | 62,150 | NS | $11,763,752 | 1.27% | EC | US |
| BioMarin Pharmaceutical Inc | 09061G101 | 207,817 | NS | $11,749,973 | 1.27% | EC | US |
| Exelixis Inc | 30161Q104 | 281,786 | NS | $11,654,669 | 1.26% | EC | US |
| Encompass Health Corp | 29261A100 | 116,362 | NS | $10,999,700 | 1.19% | EC | US |
| Intuitive Surgical Inc | 46120E602 | 21,806 | NS | $10,995,021 | 1.19% | EC | US |
| Alnylam Pharmaceuticals Inc | 02043Q107 | 31,058 | NS | $10,499,467 | 1.13% | EC | US |
| Revvity Inc | 714046109 | 85,104 | NS | $9,259,315 | 1.00% | EC | US |
| Johnson & Johnson | 478160104 | 39,785 | NS | $9,041,141 | 0.98% | EC | US |
| ResMed Inc | 761152107 | 34,184 | NS | $8,830,069 | 0.95% | EC | US |
| Medtronic PLC | 000000000 | 85,715 | NS | $8,825,216 | 0.95% | EC | IE |
| Becton Dickinson & Co | 075887109 | 42,426 | NS | $8,632,842 | 0.93% | EC | US |
Showing 1–50 of 78 holdings
Key facts
CIK
1383496
CUSIP
33733C108
13F (30d)
28 filings
28 filers